Skip to main content
Cencora10-Q: Acquisition completed

Cencora completed its acquisition of OneOncology in February 2026, financed with over $4B in debt

What happened

Cencora financed the major acquisition of OneOncology with $4.5B in new debt facilities, indicating a complex post-merger integration is underway. This creates significant operational and IT challenges, likely requiring investment in system consolidation (ERP, finance, HR) and process harmonization.

Source

SEC EDGARAug 5, 2026

Quarterly report (Form 10-Q)

Cencora 10-Q

Filing excerpt

In connection with this facility, in February 2026, we borrowed $500 million on a variable-rate term loan that was scheduled to mature in February 2028 (the “2028 Term Loan”) and $1.0 billion on a variable-rate term loan that matures in February 2029 (the “2029 Term Loan”) to finance a portion of the acquisition of OneOncology.

sec.gov/Archives/edgar/data/1140859/000114085926000034/cor-20260630.htmRead the full source

Other signals in this filing (8)

Extracted by Autobound

From the Signal API record
Signal
10-Q: Acquisition completed

What this signalsIntegration work after a deal often opens needs for new systems and services.

Fiscal year end
06/30
Filed
Aug 5, 2026

More 10-Q signals at other companies

The full record

From the Signal API record

Numbers

Dollar figure
$4.5B (Debt financing for OneOncology acquisition)

Details

CIK
1140859
Accession number
0001140859-26-000034
Timeframe
Current year
Filing year
2026
Fiscal year
0
Why it matters
Active integration needs
Signal category
Strategic

Extraction

Confidence
High
Relevance
90%
Sentiment
Positive
Detected
Aug 11, 2026
signal_type
sec-10q
signal_subtype
acquisitionCompleted

Use this data

Get every 10-Q signal for Cencora and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Cencora this week?”

  2. Send it to your own tools

    The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/c37fef54-cc9c-4835-9ee2-4fc208d40b96 returns this record as JSON. POST /v1/companies/enrich returns every signal for cencora.com.

{
  "signal_id": "c37fef54-cc9c-4835-9ee2-4fc208d40b96",
  "signal_type": "sec-10q",
  "signal_subtype": "acquisitionCompleted",
  "detected_at": "2026-08-11T08:06:31.566+00:00",
  "company": {
    "name": "Cencora",
    "domain": "cencora.com"
  },
  "data": {
    "detail": "Cencora financed the major acquisition of OneOncology with $4.5B in new debt facilities, indicating a complex post-merger integration is underway. This creates significant operational and IT challenges, likely requiring investment in system consolidation (ERP, finance, HR) and process harmonization.",
    "metrics": {
      "timeframe": "current_year",
      "dollar_context": "Debt financing for OneOncology acquisition",
      "dollar_millions": 4500
    },
    "summary": "Cencora completed its acquisition of OneOncology in February 2026, financed with over $4B in debt",
    "excerpts": "In connection with this facility, in February 2026, we borrowed $500 million on a variable-rate term loan that was scheduled to mature in February 2028 (the “2028 Term Loan”) and $1.0 billion on a variable-rate term loan that matures in February 2029 (the “2029 Term Loan”) to finance a portion of the acquisition of OneOncology.",
    "relevance": 0.9,
    "sentiment": "positive",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1140859/000114085926000034/cor-20260630.htm",
    "filing_date": "2026-08-05",
    "filing_year": 2026,
    "fiscal_year": 0,
    "fiscal_year_end": "06/30",
    "sales_relevance": "Active integration needs",
    "signal_category": "strategic"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.